Tonsillectomy Clinical Trial
Official title:
Tonsillectomy and Primitive IgA Nephropathy in Children: Strasbourg Cohort and Assessment Practices in Inter North East Region
Primitive kidney disease IgA, represented by Berger's disease and rheumatoid purpura nephropathy, are the first cause of kidney failure from chronic glomerulonephritis: changes in 20 years to end-stage renal failure is described in 10 to 30 % of cases in Berger's disease and in 15 to 20% of cases in nephropathy HSP. These two pathological entities share biological and histological characteristics, as well as common pathophysiological mechanisms, particularly the production of abnormally glycosylated IgA1 promoting their proliferation in the mesangium. Tonsils part of Iga abnormal production sites that would be associated with an infectious stimulus, tonsillectomy has been studied as a possible treatment in primitive IgA nephropathy. The benefit of tonsillectomy is controversial: many Japanese studies demonstrate its effectiveness in terms of reduction of proteinuria, improved renal function in the long term regression of histological lesions and reduced risk of relapse following clinical remission whereas European studies do not suggest its effectiveness in treating IgA nephropathy. In this context, the aim of our study is to describe the scope of practice of tonsillectomy in the treatment of primary renal disease in IgA child in the inter East region and describe the short renal become Strasbourg end of the cohort that received this treatment.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03266094 -
A Study of BiZactâ„¢ on Children and Adolescents Undergoing Tonsillectomy
|
N/A | |
Completed |
NCT02228135 -
The Effect of Dexamethasone Dosing on Post-tonsillectomy Hemorrhage
|
N/A | |
Completed |
NCT00662987 -
Effect of Duration of Antibiotic Therapy on Recovery Following Tonsillectomy
|
N/A | |
Completed |
NCT00273754 -
The Effect of Caffeine on Postextubation Adverse Respiratory Events in Children With Obstructive Sleep Apnea (OSA).
|
Phase 2 | |
Recruiting |
NCT06122948 -
Effect of Intranasal Midazolam Versus Ketamine Midazolam Combination as a Premedication on the Occurrence of Postoperative Respiratory Adverse Events
|
Phase 3 | |
Recruiting |
NCT03783182 -
Betamethasone (Betapred®) as Premedication for Reducing Postoperative Vomiting and Pain After Tonsillectomy
|
Phase 4 | |
Completed |
NCT03793816 -
Tonsillectomy Using BiZactâ„¢ - a Randomized Side-controlled Clinical Trial
|
N/A | |
Not yet recruiting |
NCT06359925 -
Suprazygomatic Nerve Block in Tonsillectomy Patients
|
N/A | |
Recruiting |
NCT06079125 -
PFDD Versus PFDRT in Chiari Decompression Surgery
|
N/A | |
Recruiting |
NCT01904461 -
HemORL: Monocentric, Prospective, Comparative Study on the Use of a Haemostatic Vacuum Device During Tonsillectomy in Children
|
N/A | |
Not yet recruiting |
NCT00756873 -
Etoricoxib in Ear Nose Throat Surgery
|
Phase 3 | |
Recruiting |
NCT05600595 -
The Evaluation of Eustachian Tube Function and Its Influencing Factors After Snoring Operation in Children
|
||
Completed |
NCT02987985 -
Efficacy of Opioid-free Anesthesia in Reducing Postoperative Respiratory Depression in Children Undergoing Tonsillectomy
|
Phase 3 | |
Completed |
NCT04066829 -
Default Dosing Settings for Opioid Prescriptions to Adolescents and Young Adults After Tonsillectomy
|
N/A | |
Recruiting |
NCT05158348 -
A Comparative Study to Measure the Effect of Nebulized Dexmedetomidine
|
Phase 3 | |
Completed |
NCT01605903 -
Postoperative Ibuprofen and the Risk of Bleeding After Tonsillectomy With or Without Adenoidectomy
|
Phase 2 | |
Enrolling by invitation |
NCT02444533 -
EXPAREL® for Pain After Tonsillectomy
|
Phase 4 | |
Recruiting |
NCT02829515 -
Tonsil Surgery in Sweden: A National Quality Register
|
||
Not yet recruiting |
NCT03491085 -
Role of Antibiotics Post Tonsillectomy
|
Phase 1/Phase 2 | |
Recruiting |
NCT05270109 -
Cold Steel Versus "Hot" BiZact Tonsillectomy; Comparing Post Tonsillectomy Morbidity
|
N/A |